Shilo Ben Zeev
Script error: No such module "Draft topics".
Script error: No such module "AfC topic".
Shilo Ben Zeev | |
---|---|
Born | |
🏳️ Nationality | Jewish-American |
💼 Occupation | Entrepreneur |
Notable work | Emulait, LabStyle Innovation, Smartzyme Biopharma, Emendo Biotherapeutics, MyBiotics and 58diagnostics |
Shilo Ben Zeev is a serial entrepreneur from Israel. He is known for establishing several companies in the medical device industry.
Biography[edit]
Ben Zeev is the founder of Emulait, a bottle-feeding company that uses 3D printing technology to biomimic the experience of breastfeeding. He has also co-founded the publicly-traded company LabStyle Innovation, which develops the Dario™ Blood Glucose Monitoring System, a smart glucose meter that connects to a diabetes management mobile application. As of 2016, Labstyle was valued at $22 million.[1][2]
Ben Zeev has also founded Smartzyme Biopharma, a diagnostics and therapeutics company that builds tools for protein engineering. The company has raised $18 million since its inception.[2] He is also the founder of $10 million-funded Emendo Biotherapeutics, which develops gene editing tools for genetic disorders, as well as MyBiotics, a microbiome pharmaceutical company.[1] He is the chief executive officer and co-founder of 58diagnostics. For his companies, Ben Zeev has received investments from organizations including Orbimed Foundation.[2]
Ben Zeev is a resident of Manhattan, New York.[3]
References[edit]
- ↑ 2.0 2.1 2.2 Weinreb Gali (16 August 2016). "Grace with the white robes is the sexiest thing in the world". Globes.
- ↑ Cohen, Nir; Lukash, Alexandra (11 January 2020). "'If you're Haredi in New York, be afraid'". Ynetnews.
This article "Shilo Ben Zeev" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Shilo Ben Zeev. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.